Raymond James Financial Inc. Reduces Holdings in Danaher Corporation $DHR

Key Points

• Raymond James Financial Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 7.5%, now holding approximately 1.58 million shares valued at $323.27 million.
• Several institutional investors increased their positions in Danaher recently, with notable increases including MGO One Seven LLC’s stake growing by 485.7% and Horizon Financial Services LLC by 20,400%.
• Danaher reported better-than-expected earnings of $1.80 EPS for the latest quarter, exceeding estimates of $1.64, along with a 3.4% year-over-year revenue increase to $5.94 billion.

Raymond James Financial Inc. lowered its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 7.5% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,576,921 shares of the conglomerate's stock after selling 127,163 shares during the period. Raymond James Financial Inc. owned approximately 0.22% of Danaher worth $323,269,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. GHP Investment Advisors Inc. lifted its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after purchasing an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth $27,000. Sierra Ocean LLC grew its position in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher in the first quarter valued at $31,000. Finally, Dunhill Financial LLC raised its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate's stock valued at $34,000 after purchasing an additional 67 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Danaher Trading Down 0.4%

NYSE:DHR traded down $0.9530 during midday trading on Wednesday, reaching $211.2470. 3,302,498 shares of the stock traded hands, compared to its average volume of 4,235,380. The stock has a market capitalization of $151.26 billion, a P/E ratio of 44.95, a PEG ratio of 2.92 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. The company has a fifty day moving average of $200.33 and a 200 day moving average of $199.54. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company's revenue for the quarter was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Argus cut their price objective on Danaher from $260.00 to $240.00 in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft cut their target price on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Scotiabank upgraded shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price objective for the company in a report on Friday, July 11th. Wells Fargo & Company cut their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating for the company in a research note on Wednesday, July 23rd. Finally, Robert W. Baird lifted their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $247.61.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.